Associate Medical Director, Clinical Research
Sumitomo Pharma America, Inc.
Summary
We are currently seeking a dynamic, highly motivated individual for the position of Associate Medical Director, Clinical Development – Oncology. This individual is responsible for the development, planning, execution, and management of clinical studies while building and maintaining relationships with investigators and key opinion leaders.
Job description
Job Duties and Responsibilities
- Demonstrate ownership of the design and implementation of a clinical protocol that supports the product development plan, based on strong medical and scientific principles. An emphasis on hematological malignancies is preferred
- Provide clinical and medical input to protocols, regulatory documents, publications, and site/investigator interactions especially in complex patient cases
- Respond to site questions related to eligibility, concomitant medication assessments, dose modification guidance, and provide investigator medical support
- Responsible for leading clinical study teams, monitoring overall study integrity, and review, interpretation, and communication of safety and efficacy data
- Conduct study support, data review and query of sites, and provide scientific leadership with clinical research scientists
- Present at scientific, medical, and regulatory meetings globally
- Develop and maintain relationships with academic investigators, pharmaceutical partners/sponsors, KOLs, and patient advocacy groups
- Contribute to company’s planned regulatory filings including authoring clinical sections for INDs, NDAs, and other related documents
- Partner with Drug Safety & Pharmacovigilance to assess the safety profile of compounds
- Maintain a high level of clinical and scientific expertise in the disease area(s) by reviewing the literature, attending medical/scientific meetings, and through personal interchanges with consultants, thought leaders, investigators, and internal stakeholders
- Author manuscripts and collaborate with cross-functional colleagues and thought leaders to meet publication plan objectives
- Maintain ethical standards of the highest level
- As required by program needs, contribute to partnership with Discovery colleagues to the design and implementation of translational strategies
- Participate in meetings and committees of parent company or other affiliates. Establish collaborative and productive relationships with the parent company, internal/external partners, and relevant affiliates. Work in close collaboration with the late-stage development group
- Perform other duties as requested
Key Core Competencies
- Ability to run a complex clinical research program with some direction
- An extensive knowledge of hematological malignancies is preferred
- Extensive knowledge of clinical trial methodology, regulatory and compliance requirements governing clinical trials, and experience in development of clinical strategy and the design of study protocols
- Proven leadership skills and ability to bring out the best in others on a cross-functional team; highly collaborative, team-oriented, and decisive
- Able to lead through influence
- Excellent communication and presentation skills are essential
Education and Experience
- Medical Doctor (MD), Doctor of Osteopathy (DO), or non-US equivalent of MD
- Completion of a residency program strongly preferred
- Completion of a subspecialty fellowship is desirable
- Experience in blood cancers or solid tumors desirable
- 0 to 3 years of pharmaceutical drug development experience required
Travel Requirements
Primarily remote role with periodic on-site meetings in office. Must be able to travel domestically and internationally as needed.
Mental/Physical Requirements
Fast-paced environment handling multiple demands is involved. Must be able to exercise appropriate judgment as necessary. Requires a high level of initiative and independence. Excellent written and oral communication skills required. Requires ability to use a personal computer for extended periods of time.
Requirements
- Medical Doctor (MD), Doctor of Osteopathy (DO), or non-US equivalent of MD
- Completion of a residency program strongly preferred
- Completion of a subspecialty fellowship is desirable
- Experience in blood cancers or solid tumors desirable
- 0 to 3 years of pharmaceutical drug development experience required
- Extensive knowledge of clinical trial methodology, regulatory and compliance requirements governing clinical trials, and experience in development of clinical strategy and the design of study protocols
- Proven leadership skills and ability to bring out the best in others on a cross-functional team; highly collaborative, team-oriented, and decisive
- Able to lead through influence
- Excellent communication and presentation skills are essential
- Must be able to travel domestically and internationally as needed
Benefits
- 401(k) plan
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Flexible paid time off
- Paid holidays
- Paid sick time
- Incentive plan
Company overview
Sumitomo Pharma America, Inc. (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. Formed in July 2023 through the consolidation of Sumitomo Pharma's U.S. affiliate companies, SMPA represents the integrated North American operations of the Japanese pharmaceutical giant. The company operates across multiple therapeutic areas including oncology, urology, women's health, rare disease, cell and gene therapies, and central nervous system disorders. With a diverse portfolio that includes six marketed products and a robust pipeline of early- to late-stage assets, SMPA leverages proprietary advanced analytics and computational technology platforms to accelerate drug discovery and development. Headquartered in Marlborough, Massachusetts, the company employs approximately 2,200 people and maintains a strong focus on maximizing the value of key products like ORGOVYX®, MYFEMBREE®, and GEMTESA® while advancing innovative treatments for unmet medical needs.